Skip to main content

Advertisement

SpringerLink
Log in

Outcome of Surgery for Acromegaly Performed by Different Surgeons: Importance of Surgical Experience

  • Published:
Pituitary Aims and scope Submit manuscript

Abstract

Aim: The aim of this study was to evaluate transsphenoidal surgery results in acromegalic patients which were performed not by a single surgeon but by different surgeons. Methods: The study included 30 (M/F: 13/17) patients whose follow-up data were available. Basal or nadir postglucose growth hormone levels of less than 2 ng/ml were accepted as cure criteria. Six of them underwent a further operation due to previous surgical failure. Results: Cure was achieved in 33% of patients while hypopituitarism was observed in 10% (3/30) of patients after the first operation. The cure rates were 63% and 15% in patients with microadenomas (n = 11) and macroadenomas (n = 19) respectively (p = 0.042). Only one of the patients (16%) who underwent a second operation achieved remission, while hypopituitarism was observed in five of them (83%). There was no significant difference in the cure rates between the first and second operation, but the risk of hypopituitarism was significantly higher in patients who underwent further surgery (p = 0.008). Conclusion: The cure rate following surgery is significantly lower in acromegalic patients with macroadenomas than in patients with microadenomas. Cure probability decreases with a further operation, while complication risk increases significantly. Octreotide therapy, which could be used as an alternative therapy to the surgery, revealed high success rates in both microadenomas and macroadenomas. The low cure rates found in this study compared with published series could be attributed to the fact that operations were performed by inexperienced surgeons.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Melmed S, Jackson I, Kleinberg D, Klibanski A. Current treatment guidelines for acromegaly. J Clin Endocrinol Metab 1998;83:2646–2652.

    CAS  PubMed  Google Scholar 

  2. Holdaway IM, Rajasoorya CR, Gamble GD, Stewart AW. Long-term treatment outcome in acromegaly. Growth Horm IGF Res 2003;13:185–192.

    CAS  PubMed  Google Scholar 

  3. Sheaves R, Jenkins P, Blackburn P, Huneidi AH, Afshar F, Medbak S, Grossman AB, Besser GM, Wass JA. Outcome of transsphenoidal surgery for acromegaly using strict criteria for surgical cure. Clin Endocrinol (Oxf) 1996;45:407–413.

    Article  CAS  Google Scholar 

  4. Abosch A, Tyrrell JB, Lamborn KR, Hannegan LT, Applebury CB, Wilson CB. Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas:initial outcome and long-term results. J Clin Endocrinol Metab 1998;83:3409–3410.

    Article  Google Scholar 

  5. Colao A, Ferone D, Marzullo P, Cappabianca P, Cirillo S, Boerlin V, Lancranjan I, Lombardi G. Long-term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly. J Clin Endocrinol Metab 2001;86:2779–2786.

    CAS  PubMed  Google Scholar 

  6. Cozzi R, Attanasio R, Montini M, Pagani G, Lasio G, Lodrini S, Barausse M,Albizzi M, Dallabonzana D, Pedroncelli AM. Four-year treatment with octreotide-long-acting repeatable in 110 acromegalic patients: Predictive value of short-term results? J Clin Endocrinol Metab 2003;88:3090–3098.

    Article  CAS  PubMed  Google Scholar 

  7. Shimon I, Cohen ZR, Ram Z, Hadani M. Transsphenoidal surgery for acromegaly: endocrinological follow-up of 98 patients. Neurosurgery 2001;48:1239–1243.

    CAS  PubMed  Google Scholar 

  8. Gittoes NJ, Sheppard MC, Johnson AP, Stewart PM. Outcome of surgery for acromegaly–the experience of a dedicated pituitary surgeon. QJM 1999;92:741–745.

    Article  CAS  PubMed  Google Scholar 

  9. Fahlbusch R, Honegger J, Buchfelder M. Evidence supporting surgery as treatment of choice for acromegaly. J Endocrinol 1997;155(Suppl 1):S53–S55.

    CAS  PubMed  Google Scholar 

  10. Lissett CA, Peacey SR, Laing I, Tetlow L, Davis JR, Shalet SM. The outcome of surgery for acromegaly: the need for a specialist pituitary surgeon for all types of growth hormone (GH) secreting adenoma. Clin Endocrinol (Oxf) 1998;49:653–657.

    Article  CAS  Google Scholar 

  11. Long H, Beauregard H, Somma M, Comtois R, Serri O, Hardy J. Surgical outcome after repeated transsphenoidal surgery in acromegaly. J Neurosurg 1996;85:239–247.

    CAS  PubMed  Google Scholar 

  12. Swearingen B, Barker FG IInd, Katznelson L, Biller BM, Grinspoon S, Klibanski A, Moayeri N, Black PM, Zervas NT. Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab 1998;83:3409–3410.

    Article  Google Scholar 

  13. Abe T, Ludecke DK. Recent results of secondary transnasal surgery for residual or recurring acromegaly. Neurosurgery 1998;42:1013–1021.

    CAS  PubMed  Google Scholar 

  14. Barrande G, Pittino-Lungo M, Coste J, Ponvert D, Bertagna X, Luton JP, Bertherat J. Hormonal and metabolic effects of radiotherapy in acromegaly: Long-term results in 128 patients followed in a single center. J Clin Endocrinol Metab 2000;85:3779–3785.

    Article  CAS  PubMed  Google Scholar 

  15. Biermasz NR, Dulken HV, Roelfsema F. Postoperative radiotherapy in acromegaly is effective in reducing GH concentration to safe levels. Clin Endocrinol (Oxf) 2000;53:321–327.

    Article  CAS  Google Scholar 

  16. Newman CB, Melmed S, George A, Torigian D, Duhaney M, Snyder P, Young W,Klibanski A, Molitch ME, Gagel R, Sheeler L, Cook D, Malarkey W, Jackson I,Vance ML, Barkan A, Frohman L, Kleinberg DL. Octreotide as primary therapy for acromegaly. J Clin Endocrinol Metab 1998;83:3031–3033.

    Article  Google Scholar 

  17. Bevan JS, Atkin SL, Atkinson AB, Bouloux PM, Hanna F, Harris PE, James RA,McConnell M, Roberts GA, Scanlon MF, Stewart PM, Teasdale E, Turner HE, Wass JA, Wardlaw JM. Primary medical therapy for acromegaly: An open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size. J Clin Endocrinol Metab 2002;87:4554–4563.

    Article  CAS  PubMed  Google Scholar 

  18. Ahmed S, Elsheikh M, Stratton IM, Page RC, Adams CB, Wass JA. Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience. Clin Endocrinol (Oxf) 1999;50:561–567.

    Article  CAS  Google Scholar 

  19. Clayton RN. How many surgeons to operate on acromegalic patients? Clin Endocrinol (Oxf) 1999;50:557–559.

    Article  CAS  Google Scholar 

  20. Attanasio R, Epaminonda P, Motti E, Giugni E, Ventrella L, Cozzi R, Farabola M, Loli P, Beck-Peccoz P, Arosio M. Gamma-knife radiosurgery in acromegaly: A 4-year follow-up study. J Clin Endocrinol Metab 2003;88:3105–3112.

    CAS  PubMed  Google Scholar 

  21. Davis DH, Laws ER Jr, Ilstrup DM, Speed JK, Caruso M, Shaw EG, Abboud CF, Scheithauer BW, Root LM, Schleck C. Results of surgical treatment for growth hormone-secreting pituitary adenomas. J Neurosurg 1993;79:70–75.

    CAS  PubMed  Google Scholar 

  22. Orme SM, McNally RJ, Cartwright RA, Belchetz PE. Mortality and cancer incidence in acromegaly: A retrospective cohort study. United Kingdom Acromegaly Study Group. J Clin Endocrinol Metab 1998;83:2730–2734.

    Article  CAS  PubMed  Google Scholar 

  23. Bates AS, Van't Hoff W, Jones JM, Clayton RN. An audit of outcome of treatment in acromegaly. Q J Med 1993;86:293–299.

    CAS  PubMed  Google Scholar 

  24. Holdaway IM, Rajasoorya C. Epidemiology of acromegaly. Pituitary 1999;2(1):29–41.

    Article  CAS  PubMed  Google Scholar 

  25. Biermasz NR, van Dulken H, Roelfsema F. Ten-year follow-up results of transsphenoidal microsurgery in acromegaly. J Clin Endocrinol Metab 2000;85:4596–4602.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology, Uludag University, School of Medicine, 16059, Bursa, Turkey

    Erdinc Erturk, Ercan Tuncel, Sinem Kiyici, Canan Ersoy, Cevdet Duran & Sazi Imamoglu

Authors
  1. Erdinc Erturk
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ercan Tuncel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sinem Kiyici
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Canan Ersoy
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Cevdet Duran
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sazi Imamoglu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Erdinc Erturk.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Erturk, E., Tuncel, E., Kiyici, S. et al. Outcome of Surgery for Acromegaly Performed by Different Surgeons: Importance of Surgical Experience. Pituitary 8, 93–97 (2005). https://doi.org/10.1007/s11102-005-3280-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11102-005-3280-9

Key Words

Search

Navigation